Search results for "modification"

showing 10 items of 853 documents

"Table 34" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …

2017

Nuclear modification factor of $\phi$ as a function of $p_{\rm T}$ for 0-5$\%$ in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76~{\rm TeV}$.

2760.0Nuclear modification factorPB PB --> Phi X
researchProduct

"Table 37" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …

2017

Nuclear modification factor of $\phi$ as a function of $p_{\rm T}$ for 40-50$\%$ in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76~{\rm TeV}$.

2760.0Nuclear modification factorPB PB --> Phi X
researchProduct

Spray dried hyaluronic acid microparticles for adhesion controlled aggregation and potential stimulation of stem cells

2017

Spray-dried microparticles of a derivative of hyaluronic acid (HA) have been engineered to obtain a controlled aggregation with Human Mesenchymal Stem Cells (hMSCs) into 3D constructs. We demonstrated the utility of chemical functionalization of a native constituent of the extracellular matrix to improve processing performances and to control on stem cell adhesion and differentiation. Native hyaluronic acid (HA), cell adhesive peptides (RGD), transforming growth factor β3, dexamethasone are biological agents potentially suitable for chondrogenic stimulation of hMSCS. However unmodified HA suffers of drawbacks in terms of stability and versatility of processing. Functionalization strategies…

3003Hyaluronic acid0206 medical engineeringPharmaceutical Science02 engineering and technologyDexamethasoneExtracellular matrixchemistry.chemical_compoundTissue engineeringTransforming Growth Factor betaHyaluronic acidCell AdhesionHumansCell adhesionCells CulturedBottom-up approachStem cellMesenchymal Stromal CellTissue EngineeringChemistryMesenchymal stem cellMesenchymal Stem CellsCell DifferentiationAdhesion021001 nanoscience & nanotechnology020601 biomedical engineeringExtracellular MatrixBiochemistryMicroparticleSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoSurface modificationChondrogenesiStem cell0210 nano-technologyChondrogenesisHuman
researchProduct

Enhanced adhesion and in situ photothermal ablation of cancer cells in surface-functionalized electrospun microfiber scaffold with graphene oxide

2017

The physicochemical characteristics of a biomaterial surface highly affect the interaction with living cells. Recently, much attention has been focused on the adhesion properties of functional biomaterials toward cancer cells, since is expected to control metastatic spread of a tumor, which is related to good probability containing the progression of disease burden. Here, we designed an implantable poly(caprolactone)-based electrospun microfiber scaffold, henceforth PCLMF-GO, to simultaneously capture and kill cancer cells by tuning physicochemical features of the hybrid surface through nitrogen plasma activation and hetero-phase graphene oxide (GO) covalent functionalization. The surface i…

3003business.product_categoryCancer therapyPharmaceutical ScienceNanotechnologyBiocompatible Materials02 engineering and technologyCell capture010402 general chemistry01 natural scienceslaw.inventionPlasmalawNeoplasmsMicrofiberCell AdhesionHumansCell adhesionGraphene oxideHybrid materialChemistryGrapheneBiomaterialOxidesAdhesionPhotothermal therapyPhototherapy021001 nanoscience & nanotechnology0104 chemical sciencesPolycaprolactoneCancer cellMCF-7 CellsSurface modificationGraphite0210 nano-technologybusiness
researchProduct

"Table 8" of "$\Upsilon$ production and nuclear modification at forward rapidity in Pb-Pb collisions at $\mathbf{\sqrt{\textit{s}_{\textbf{NN}}}=5.02…

2021

Nuclear modification factor of $\Upsilon(1\mathrm{S})$ as a function of transverse momentum for the 0–90% centrality interval.

5020.0High Energy Physics::ExperimentUpsilonNuclear ExperimentPb Pb --> UPSI(1S) < MU+ MU- > XTransverse Momentum DependenceLead-Lead ScatteringRAANuclear Modification Factor
researchProduct

"Table 7" of "Dielectron production in proton-proton and proton-lead collisions at $\sqrt{s_{\rm{NN}}}$ = 5.02 TeV"

2020

Dielectron nuclear modification factor $R_{\rm pPb}$ at $\sqrt{s}$ = 5.02 TeV as a function of $m_{\rm ee}$. Electrons are measured within $|\eta_{\rm e}| < 0.8$ and $p_{\rm T,e} > 0.2$ GeV/$c$.

5020.0P P --> E+ E- XDielectron nuclear modification factorDSIG/DMP PB --> E+ E- X
researchProduct

"Table 8" of "Dielectron production in proton-proton and proton-lead collisions at $\sqrt{s_{\rm{NN}}}$ = 5.02 TeV"

2020

Dielectron nuclear modification factor $R_{\rm pPb}$ at $\sqrt{s}$ = 5.02 TeV as a function of $p_{\rm T,ee}$ for $0.5 < m_{\rm ee} < 1.1$ GeV/$c$. Electrons are measured within $|\eta_{\rm e}| < 0.8$ and $p_{\rm T,e} > 0.2$ GeV/$c$.

5020.0P P --> E+ E- XDielectron nuclear modification factorP PB --> E+ E- XDSIG/DPTEE
researchProduct

"Table 9" of "Dielectron production in proton-proton and proton-lead collisions at $\sqrt{s_{\rm{NN}}}$ = 5.02 TeV"

2020

Dielectron nuclear modification factor $R_{\rm pPb}$ at $\sqrt{s}$ = 5.02 TeV as a function of $p_{\rm T,ee}$ for $1.1 < m_{\rm ee} < 2.7$ GeV/$c$. Electrons are measured within $|\eta_{\rm e}| < 0.8$ and $p_{\rm T,e} > 0.2$ GeV/$c$.

5020.0P P --> E+ E- XDielectron nuclear modification factorP PB --> E+ E- XDSIG/DPTEE
researchProduct

"Table 9" of "$\Upsilon$ production and nuclear modification at forward rapidity in Pb-Pb collisions at $\mathbf{\sqrt{\textit{s}_{\textbf{NN}}}=5.02…

2021

Nuclear modification factor of $\Upsilon(1\mathrm{S})$ as a function of rapidity for the 0–90% centrality interval.

5020.0Rapidity DependenceUpsilonPb Pb --> UPSI(1S) < MU+ MU- > XLead-Lead ScatteringRAANuclear Modification Factor
researchProduct

"Table 10" of "$\Upsilon$ production and nuclear modification at forward rapidity in Pb-Pb collisions at $\mathbf{\sqrt{\textit{s}_{\textbf{NN}}}=5.0…

2021

Nuclear modification factor of $\Upsilon(2\mathrm{S})$ as a function of rapidity for the 0–90% centrality interval.

5020.0Rapidity DependenceUpsilonPb Pb --> UPSI(2S) < MU+ MU- > XLead-Lead ScatteringRAANuclear Modification Factor
researchProduct